Who has invested in Amolyt Pharma?

Sofinnova Partners, LSP, Novo Ventures, Kurma Partners, OrbiMed, EQT Life Sciences are named among the investors backing Amolyt Pharma.

Amolyt Pharma Funding: $210M Raised, Series C (2023)

Amolyt Pharma funding overview

Amolyt Pharma is based in Lyon, France. Amolyt Pharma has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2023. The round record for Amolyt Pharma runs through 2023; nothing later has been disclosed. Investors on record include Sofinnova Partners, LSP, Novo Ventures, Kurma Partners, OrbiMed, EQT Life Sciences and 2 others. 8 distinct backers are named across the disclosed rounds.

Amolyt Pharma at a glance

Total raised: $210M
Latest round: Series C
Latest round date: January 2023
Headquarters: Lyon, France
Notable investors: Sofinnova Partners, LSP, Novo Ventures, Kurma Partners, OrbiMed, EQT Life Sciences, Mass General Brigham Ventures, RA Capital Management

Frequently asked about Amolyt Pharma funding

How much has Amolyt Pharma raised?: Amolyt Pharma has raised $210M in total disclosed funding across the rounds on record.
Who has invested in Amolyt Pharma?: Sofinnova Partners, LSP, Novo Ventures, Kurma Partners, OrbiMed, EQT Life Sciences are named among the investors backing Amolyt Pharma.
What was the latest Amolyt Pharma funding round?: The most recent disclosed round is a Series C, announced in January 2023.
Where is Amolyt Pharma based?: Amolyt Pharma is based in Lyon, France.
When did Amolyt Pharma last raise?: The last disclosed Amolyt Pharma round closed in January 2023 at Series C.

Amolyt Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lyon below to benchmark round size and investor mix.

Amolyt Pharma Funding: $210M Raised, Series C (2023)

Amolyt Pharma funding overview

Amolyt Pharma at a glance

Frequently asked about Amolyt Pharma funding

Companies related to Amolyt Pharma (36)

Browse related funding lists (8)